Members of the family who own OxyContin maker Purdue Pharma agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of OxyContin.

The new settlement deal could net Pennsylvania and Delaware as much as $212 million and $27 million, respectively, in payouts.

A bipartisan coalition of states has reached a $7.4 billion settlement in principle with members of the Sackler family and their former company Purdue Pharma over their role in the opioid crisis.

A settlement was reached in principal between Purdue Pharma, the Sackler Family, states, and the victims of the opioid crisis.

Petrified wood is one of the most sought-after materials in the world for both its aesthetic value and its scientific value. But in Indonesia, miners who risk their lives to dig it up barely make ...

Welcome back to the Big Ten Basketball Midweek Rundown. First, a look at where each Big Ten team stands in the latest version of the AP poll, as well as going o ...

Purdue Pharma and the Sackler families agreed Thursday to increase their financial contribution to $7.4 billion to resolve mass opioid litigation.

Under the newest version of the settlement, the Sacklers would only be immune from prosecution by individuals who agreed to it.

The Wolverines visit the Boilermakers as we continue our college basketball odds series with a Michigan-Purdue prediction and pick.

A settlement has been reached in a lawsuit, as owners of Purdue Pharma will pay billions over their role in the opioid crisis. The settlement was announced Thursday.

The ship has sailed on Indiana contending for the Big Ten title. But there are winnable games left on the schedule.

Purdue Pharma, under the leadership of the Sackler family, manufactured and sold opioids like Oxycontin for decades.